PURPOSE: Our interest is to report our experience about the use of Nd YAG laser in the field of inoperable lung cancers.
METHODS: Between the years of 2003 to 2005, 110 patients with obstructive Endobronchial Lesions were studied (77 men, 33 women) for evaluating of the palliative role of LASER resection. Histopathologic categories concluded of, Adenocarcinoma (23.28%), Squamous Cell Carcinoma (26.02%), Bronchogenic carcinoma, unspecified (21.8%), Large cell carcinoma (4.01%), Adenoid cystic carcinoma (9.58%), Metastatic cancers (6.84%) and direct invasive cancers (8.21%). Initial symptoms were of, dyspnea (92%), productive cough (83.2%), non massive Hemoptysis (68%), massive Hemoptysis (10%), pleuretic chest pain (46%) and respiratory failure (3.2%).
RESULTS: After 3 sessions of laser resection (which was the mean number of LASER therapy sessions) symptoms of Dyspnea, Non massive hemoptysis, Productive cough, Pleuretic chest pain seen in 68%, 23.8%, 64.2%, 32.5%, respectively. One year after initial LASER resection, symptoms were significantly relieved in 36.3% of all cases. Moderate decrease of the symptoms was seen in 41.6% of patients. No considerable changes were seen in the symptoms of the remaining cases. The average of survival time in our patients was 223 days.
CONCLUSION: We conclude that LASER resection is a method that could be used for ablation of Endobronchial Malignant Lesions specially in patients with inoperable obstructing tumor.
CLINICAL IMPLICATIONS: There was no complication in our study.
DISCLOSURE: Hamid Reza Jabbardarjani, None.